Aerosol Delivery Methods for Chronic Obstructive Pulmonary Disease

This trial explores how different delivery methods of albuterol (also known as Salbutamol or Ventolin) might affect breathing in people with chronic obstructive pulmonary disease (COPD). The researchers aim to determine if using various inhalation devices alters airflow through the lungs. Participants will use each device and undergo MRI scans to assess lung function. The trial suits those with COPD who have been on standard treatments for at least six months and have not experienced recent breathing issues or medication changes. As a Phase 1 trial, this research focuses on understanding how the treatment works in people, offering participants a chance to contribute to foundational knowledge about their condition.

Research has shown that albuterol, a medicine that helps people breathe easier, is usually safe when inhaled in different ways. Studies have tested albuterol with both jet nebulizers and metered dose inhalers, finding it safe and effective for many people. In these studies, hundreds of people used albuterol, and most did not experience serious side effects. The most common mild side effects included a fast heartbeat and feeling shaky, but these effects were short-lived.

Researchers are excited about this trial because it explores how different aerosol delivery methods impact the effectiveness of albuterol in treating COPD. Albuterol is a common bronchodilator used to open airways, but this trial specifically compares delivery via a jet nebulizer, a metered dose inhaler, and a vibrating mesh nebulizer. Each method could potentially optimize how quickly and efficiently the medication reaches the lungs, leading to better symptom control. By using advanced MRI imaging with hyperpolarized xenon, researchers hope to understand which method offers the best improvement in lung ventilation, potentially setting the stage for more personalized COPD treatments.

Studies have shown that albuterol improves lung function in people with breathing problems. In this trial, participants will receive albuterol through various delivery methods. Research suggests that a jet nebulizer can enhance lung function more effectively than other methods. The vibrating mesh nebulizer also shows promise, delivering medication efficiently and leading to quicker improvement. Albuterol delivered by a metered dose inhaler provides fast relief for breathing issues. Overall, each method has proven effective in improving breathing, which is crucial for individuals with chronic obstructive pulmonary disease (COPD).⁶⁷⁸⁹¹⁰